Statement of Deviation or Variation under Regulation 32 of SEBI (LODR) Regulations, 2015.
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Oct 23 2024
- Welcure Drugs and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Newspaper Publication
Later from Welcure Drugs and Pharmaceuticals
- Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015.
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Nov 07 2024
- Board Meeting Intimation for Postponement Of Board Meeting
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Nov 13 2024
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals LimitedHeld On Today I.E. Thursday, 14Th November, 2024.
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals